348 related articles for article (PubMed ID: 28832451)
1. Induction Therapy, Rejection, and Graft Outcomes in Pediatric and Adolescent Kidney Transplant Recipients.
Mincham CM; Wong G; Teixeira-Pinto A; Kennedy S; Alexander S; Larkins N; Lim WH
Transplantation; 2017 Sep; 101(9):2146-2151. PubMed ID: 28832451
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
[TBL] [Abstract][Full Text] [Related]
3. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
[TBL] [Abstract][Full Text] [Related]
4. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
[TBL] [Abstract][Full Text] [Related]
5. Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents.
Whitson BA; Kilic A; Lehman A; Wehr A; Hasan A; Haas G; Hayes D; Sai-Sudhakar CB; Higgins RS
Clin Transplant; 2015 Jan; 29(1):9-17. PubMed ID: 25284138
[TBL] [Abstract][Full Text] [Related]
6. Waiting Time Between Failure of First Graft and Second Kidney Transplant and Graft and Patient Survival.
Wong G; Chua S; Chadban SJ; Clayton P; Pilmore H; Hughes PD; Ferrari P; Lim WH
Transplantation; 2016 Aug; 100(8):1767-75. PubMed ID: 26457605
[TBL] [Abstract][Full Text] [Related]
7. Effect of Induction Therapy on Graft Survival in Primary Pediatric Heart Transplantation: A Propensity Score Analysis of the UNOS Database.
Butts R; Davis M; Savage A; Burnette A; Kavarana M; Bradley S; Atz A; Nietert PJ
Transplantation; 2017 Jun; 101(6):1228-1233. PubMed ID: 27362312
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated and humoral acute vascular rejection and graft loss: A registry study.
Teo RZ; Wong G; Russ GR; Lim WH
Nephrology (Carlton); 2016 Feb; 21(2):147-55. PubMed ID: 26243593
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 receptor antibody reduces rejection rates and graft loss in live-donor kidney transplant recipients.
Lim WH; Chang SH; Chadban SJ; Campbell SB; Dent H; Russ GR; McDonald SP
Transplantation; 2009 Nov; 88(10):1208-13. PubMed ID: 19935375
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Antibody-Based Induction Therapy in Deceased Donor Kidney Transplantation in the United States.
Gharibi Z; Ayvaci MUS; Hahsler M; Giacoma T; Gaston RS; Tanriover B
Transplantation; 2017 Jun; 101(6):1234-1241. PubMed ID: 27379555
[TBL] [Abstract][Full Text] [Related]
11. Graft and patient outcomes of zero-human leucocyte-antigen-mismatched deceased and live donor kidney transplant recipients.
Lim WH; Gray NA; Chadban SJ; Pilmore H; Wong G
Transpl Int; 2015 May; 28(5):610-8. PubMed ID: 25689280
[TBL] [Abstract][Full Text] [Related]
12. Age-specific risk of renal graft loss from late acute rejection or non-compliance in the adolescent and young adult period.
Ritchie AG; Clayton PA; McDonald SP; Kennedy SE
Nephrology (Carlton); 2018 Jun; 23(6):585-591. PubMed ID: 28452103
[TBL] [Abstract][Full Text] [Related]
13. Maternal compared with paternal donor kidneys are associated with poorer graft outcomes after kidney transplantation.
Lim WH; McDonald SP; Coates PT; Chapman JR; Russ GR; Wong G
Kidney Int; 2016 Mar; 89(3):659-65. PubMed ID: 26880459
[TBL] [Abstract][Full Text] [Related]
14. Association Between Delayed Graft Function and Graft Loss in Donation After Cardiac Death Kidney Transplants-A Paired Kidney Registry Analysis.
Lim WH; McDonald SP; Russ GR; Chapman JR; Ma MK; Pleass H; Jaques B; Wong G
Transplantation; 2017 Jun; 101(6):1139-1143. PubMed ID: 28538652
[TBL] [Abstract][Full Text] [Related]
15. Effect of interleukin-2 receptor antibody therapy on acute rejection risk and severity, long-term renal function, infection and malignancy-related mortality in renal transplant recipients.
Lim W; Chadban S; Campbell S; Dent H; Russ G; McDonald S
Transpl Int; 2010 Dec; 23(12):1207-15. PubMed ID: 20536789
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.
Lentine KL; Schnitzler MA; Xiao H; Brennan DC
Trials; 2015 Aug; 16():365. PubMed ID: 26285695
[TBL] [Abstract][Full Text] [Related]
17. The risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporine.
Lim WH; Russ GR; Wong G; Pilmore H; Kanellis J; Chadban SJ
Kidney Int; 2017 Apr; 91(4):954-963. PubMed ID: 28109543
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes associated with induction regimens among retransplant kidney recipients in the United States.
Schold J; Poggio E; Goldfarb D; Kayler L; Flechner S
Transplantation; 2015 Jun; 99(6):1165-71. PubMed ID: 25606788
[TBL] [Abstract][Full Text] [Related]
19. Association Between Slow and Delayed Graft Function With Graft Outcomes in Pediatric and Adolescent Deceased Donor Kidney Transplant Recipients.
Lim WH; McDonald SP; Kennedy SE; Larkins N; Wong G
Transplantation; 2017 Aug; 101(8):1906-1912. PubMed ID: 27575687
[TBL] [Abstract][Full Text] [Related]
20. Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients.
Taber DJ; McGillicuddy JW; Bratton CF; Rohan VS; Nadig S; Dubay D; Baliga PK
Ann Surg; 2017 Sep; 266(3):450-456. PubMed ID: 28654544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
